Clinical Research Directory

Browse clinical research sites, groups, and studies.

Sites Groups Studies

Back to Studies

RECRUITING

NCT04838171

Prospective Study of White Blood Cells

Sponsor: Quell Therapeutics Limited

View on ClinicalTrials.gov

Summary

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Official title: Investigation of White Blood Cells to Support the Development of Engineered Regulatory T Cell (Treg) Therapies

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

Start Date

2021-03-24

Completion Date

2030-01

Last Updated

2026-01-21

Healthy Volunteers

Yes

Conditions

Autoimmune Diseases Inflammation Rejection; Transplant, Liver

Interventions

OTHER

White blood cell and blood collection

Mononucleocytes will be collected via apheresis

Locations (1)

Quell Investigator Site 01

London, United Kingdom